Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Kok · SciRah

Researcher profile · Semantic Scholar

K. Kok

Share profile

K. Kok — researcher profile on SciRah

h-index: 24
Works: 117
Citations: 2,320

Most-cited papers

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
N. Kennedy, Simeng Lin, J. Goodhand, N. Chanchlani +22 more
2021Gut263 citations Open access
Semantic Scholar
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
N. Noor, James C. Lee, S. Bond, F. Dowling +38 more
2024The Lancet Gastroenterology and Hepatology203 citations Open access
Semantic Scholar
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
N. Kennedy, J. Goodhand, C. Bewshea, R. Nice +27 more
2021Gut166 citations Open access
Semantic Scholar
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025
Gordon W Moran, Morris Gordon, V. Sinopolou, S. Radford +32 more
2025Gut164 citations Open access
Semantic Scholar
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
J. Alexander, N. Kennedy, H. Ibraheim, S. Anandabaskaran +58 more
2022The Lancet Gastroenterology and Hepatology110 citations Open access
Semantic Scholar
Fecal Calprotectin.
R. Ayling, K. Kok
2018Advances in Clinical Chemistry96 citations
Semantic Scholar
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
Simeng Lin, N. Kennedy, A. Saifuddin, D. M. Sandoval +28 more
2022Nature Communications74 citations Open access
Semantic Scholar
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study
J. Alexander, Zhigang Liu, Diana Muñoz Sandoval, C. Reynolds +65 more
2022The Lancet Gastroenterology and Hepatology53 citations Open access
Semantic Scholar
IBD in pregnancy: recent advances, practical management
C. Selinger, C. Nelson-Piercy, A. Fraser, Veronica Hall +11 more
2020Frontline Gastroenterology49 citations Open access
Semantic Scholar
Reduced CD27−IgD− B Cells in Blood and Raised CD27−IgD− B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease
C. Pararasa, Na Zhang, T. Tull, M. H. Chong +8 more
2019Frontiers in Immunology45 citations Open access
Semantic Scholar
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
N. Chanchlani, Simeng Lin, D. Chee, B. Hamilton +21 more
2021Journal of Crohn's & Colitis44 citations Open access
Semantic Scholar
Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies
R. Curciarello, T. Sobande, Samantha Jones, P. Giuffrida +4 more
2020Journal of Inflammation Research38 citations Open access
Semantic Scholar
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic
N. Kennedy, M. Janjua, N. Chanchlani, Simeng Lin +19 more
2022Gut37 citations Open access
Semantic Scholar
Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society
C. Selinger, N. Carey, Shelley Cassere, C. Nelson-Piercy +12 more
2020Frontline Gastroenterology36 citations Open access
Semantic Scholar
Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.
M. Samaan, K. Forsyth, J. Segal, D. D. de Jong +28 more
2019Journal of Crohn's & Colitis32 citations Open access
Semantic Scholar
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, K. Le, Xin Zhou, J. Alexander +18 more
2022The Lancet Gastroenterology and Hepatology29 citations Open access
Semantic Scholar
Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience
H. Ibraheim, M. Samaan, A. Srinivasan, O. Brain +16 more
2020Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology27 citations Open access
Semantic Scholar
Fecal Calprotectin in Gastrointestinal Disease.
J. Murray, K. Kok, R. Ayling
2023Clinical Chemistry26 citations
Semantic Scholar
The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
B. Crooks, Ravi Misra, N. Arebi, K. Kok +3 more
2021Intestinal Research26 citations Open access
Semantic Scholar
New Therapeutic Strategies
K. Kok, A. Ibarra, J. Lindsay
2019Inflammatory Bowel Disease Nursing Manual18 citations
Semantic Scholar
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
S. Honap, L. Al‐Hillawi, S. Baillie, A. Bancil +7 more
2022Frontline Gastroenterology16 citations Open access
Semantic Scholar
Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients
Simeng Lin, N. Kennedy, A. Saifuddin, D. M. Sandoval +28 more
202116 citations Open access
Semantic Scholar
Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease
S. Carlson, L. Mathew, M. Savage, K. Kok +3 more
2023Journal of Fungi13 citations Open access
Semantic Scholar
Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study
Andrew A. Plumb, Gordon W. Moran, K. Chowdhury, Norin Ahmed +51 more
2025Inflammatory Bowel Diseases12 citations Open access
Semantic Scholar
Understanding and managing psychological disorders in patients with inflammatory bowel disease: a practical guide
K. Kok, P. Byrne, A. Ibarra, Peter Martin +1 more
2022Frontline Gastroenterology12 citations Open access
Semantic Scholar
Provision of care for pregnant women with IBD in the UK: the current landscape
Sarah Wolloff, E. Moore, T. Glanville, J. Limdi +6 more
2020Frontline Gastroenterology12 citations Open access
Semantic Scholar
Appropriateness of small molecule agents for patients with IBD of childbearing age – a RAND/UCLA appropriateness panel
Christian Selinger, R. Laube, J. Limdi, K. Headley +8 more
2024Therapeutic Advances in Gastroenterology11 citations Open access
Semantic Scholar
The dietary practices and beliefs of people living with older-onset inflammatory bowel disease
B. Crooks, Ravi Misra, N. Arebi, K. Kok +3 more
2021European Journal of Gastroenterology and Hepathology11 citations
Semantic Scholar
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib
Zhigang Liu, James L. Alexander, Yee-Eng Kai, H. Ibraheim +29 more
2023Journal of Crohn's & Colitis9 citations Open access
Semantic Scholar
Nutritional care pathways in cancer patients with malignant bowel obstruction: A retrospective multi-centre study.
P. S. Patel, K. Fragkos, N. Keane, D. Wilkinson +18 more
2023Clinical Nutrition ESPEN8 citations
Semantic Scholar
Human Intestinal Dendritic Cells Can Overcome Retinoic Acid Signaling to Generate Proinflammatory CD4 T Cells with Both Gut and Skin Homing Properties.
Hannah Gordon, Katherine Wichmann, A. Lewis, T. Sanders +7 more
2023Journal of Immunology7 citations
Semantic Scholar
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study
Zhigang Liu, James L. Alexander, K. Le, Xin Zhou +68 more
2023EClinicalMedicine7 citations Open access
Semantic Scholar
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab
C. Miller, H. Kwok, P. Harrow, R. Vega +27 more
2022Frontline Gastroenterology5 citations Open access
Semantic Scholar
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
S. Lin, N. Kennedy, A. Saifuddin, D. M. Sandoval +29 more
2021medRxiv5 citations Open access
Semantic Scholar
P318 Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
R. Gadhok, R. Rao, S. Honap, M. Samaan +15 more
2019Journal of Crohn's & Colitis5 citations
Semantic Scholar
P514 Beyond the First Attempt: A Multi-Centre UK Analysis of Second JAK Inhibitor Use in Ulcerative Colitis
Y. Danso, C. Radia, A. Kent, P. Harrow +36 more
2024Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy
A. Moens, C. J. van der Woude, M. Julsgaard, S. Sebastian +24 more
2019Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients
S. Lin, N. Kennedy, A. Saifuddin, D. M. Sandoval +28 more
2022Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab
J. Alexander, N. Kennedy, H. Ibraheim, S. Anandabaskaran +27 more
2022Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
Pyodermatitis vegetans–pyostomatitis vegetans with ocular involvement
L. Steele, S. Jeetle, K. Kok, M. Cunningham +1 more
2020Clincal and Experimental Dermatology3 citations
Semantic Scholar
Su1846 – Outcomes of Pregnancy in IBD Patietns Treated with Vedolizumab, Anti-TNF Or Conventional Therapy
A. Moens, C. J. van der Woude, Mette Julsgaard, S. Sebastian +24 more
2019Gastroenterology3 citations
Semantic Scholar
Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial.
Nuru Noor, M. Sharip, Hai-Yan Zheng, B. Widmer +38 more
2026The Lancet Gastroenterology and Hepatology2 citations Open access
Semantic Scholar
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes
Keith Bodger, C. Booker, F. Taylor, Tariq Ahmad +6 more
2026Therapeutic Advances in Gastroenterology2 citations Open access
Semantic Scholar
Inter- and intra-observer variability of software quantified bowel motility measurements of small bowel Crohn’s disease: findings from the MOTILITY trial
M. Hameed, Andrew A. Plumb, K. Chowdhury, Norin Ahmed +77 more
2025Insights into Imaging2 citations Open access
Semantic Scholar
OP01 PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease
N. Noor, J. Lee, S. Bond, F. Dowling +35 more
2024Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
OP24 Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with Inflammatory Bowel Disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study
Z. Liu, K. Le, X. Zhou, J. Alexander +18 more
2023Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Inflammatory bowel disease in pregnancy: Developing a multidisciplinary care pathway in East London
M. Kaler, Madeleine Malina, K. Kok, Rehan U. Khan
2021Obstetric Medicine2 citations Open access
Semantic Scholar
P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort
R. Gadhok, K. Fragkos, S. Honap, J. Hassan +13 more
20202 citations Open access
Semantic Scholar
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease
N. Noor, Hai-Yan Zheng, Zhi Cao, Gianmarco Caruso +14 more
2026Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
DOP041 Pregnancy and Infant Outcomes After In Utero Exposure to JAK Inhibitors in Inflammatory Bowel Disease: A Global Multicenter Cohort Study
M. Julsgaard, S. M. Baunwall, C. Seow, D. Ďuricová +20 more
2026Journal of Crohn's & Colitis1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Lees×16
Invite
C. Lees — researcher profile on SciRah
R. Nice×15
Invite
R. Nice — researcher profile on SciRah
C. Bewshea×13
Invite
C. Bewshea — researcher profile on SciRah
P. Irving×13
Invite
P. Irving — researcher profile on SciRah

×12

Invite

J. Goodhand — researcher profile on SciRah

Invite

R. Boyton — researcher profile on SciRah

S. Sebastian×11

Invite

S. Sebastian — researcher profile on SciRah

N. Chanchlani×10

Invite

N. Chanchlani — researcher profile on SciRah

Invite

A. Hart — researcher profile on SciRah

Invite

N. Kennedy — researcher profile on SciRah

A. Saifuddin×9

Invite

A. Saifuddin — researcher profile on SciRah

L. Constable×9

Invite

L. Constable — researcher profile on SciRah